Companies / Lyell Immunopharma, Inc. / Activity
Activity — Lyell Immunopharma, Inc.
20 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | ARCH Venture Management, LLC 13F manager | Add | Common Stock | $9.79M | +488K +17.69% | 3,247,162 13.25% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common Stock | $8.03M | +400K +682.43% | 458,905 1.87% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $7.62M | +543K +298.35% | 724,342 2.96% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $1.88M | +134K +260.04% | 185,322 0.76% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common Stock | $1.54M | +77K +194.79% | 116,411 0.48% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | Common Stock | $1.51M | +75K +102.57% | 148,516 0.61% of shares | low |
| Q1 2026 as of | RBF Capital, LLC 13F manager | Trim | Common Stock | $-611.6K | -30K -40.88% | 44,094 0.18% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $454.8K | +15K +1239.51% | 15,967 0.07% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $129.1K | +9K | 9,188 0.04% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $103.6K | +3K +71.94% | 8,045 0.03% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common Stock | $-80.9K | -4K -25.81% | 11,585 0.05% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $79.9K | +4K +2.44% | 166,980 0.68% of shares | low |
| Q1 2026 as of | CPPIB Crestone Peak Resources Canada Inc. 13F manager | Trim | Common Stock | $-54.2K | -3K -8.41% | 29,411 0.12% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Trim | Common Stock | $-21.5K | -1K -33.85% | 2,097 <0.01% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common Stock | $10.2K | +1K | 1,155 <0.01% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common Stock | $9.0K | +447 | 447 <0.01% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Add | Common Stock | $5.4K | +227 +945.83% | 251 <0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $601 | +37 +3.20% | 1,192 <0.01% of shares | low |
| Q2 2026 as of | Gf Fund Management Co. Ltd. 13F manager | Add | Common Stock | $506 | +36 +8.65% | 452 <0.01% of shares | low |
| Q4 2025 as of | IFP Advisors, Inc 13F manager | Exit | Common Stock | $-16 | -1 -100.00% | 0 | low |